Clinical cases, pathogenesis and diagnosis of catatonia in affective disorders (depression and mania) in adolescents
- Pages
- 104-124
Abstract
Catatonia is an important syndrome found in both psychiatry and general medicine. However, identification and treatment of this phenomenon is difficult without modern diagnostic scales for catatonia.
Purpose — to describe the cases of inhibited and excitable catatonia in adolescents with affective disorders.
Methods — clinical observation in accordance with the ICD-10 diagnostic criteria for affective disorders in depression and mania, the use of Beck depression scale, Beck anxiety scale, Young scale of mania, Bush-Francis catatonia rating scale. Differential diagnosis with the participation of a team of specialists: neurologist, psychiatrist, clinical psychologist, cardiologist, infectious disease specialist, pediatrician.
Results and discussion. Catatonia in children occurs in various conditions that are not always associated with schizophrenia: with general developmental disorders, epilepsy, affective disorders, sports injuries of the cervical spine. Difficulties in recognizing and appropriately treating catatonia can lead to poor patient outcomes due to inappropriate treatment that aggravates the course of catatonia. The most effective treatment for catatonia is benzodiazepine tranquilizers and / or electroconvulsive therapy; the latter is the method of last choice if the early administration of benzodiazepine derivatives has been missed, or they are ineffective even at high doses. The use of a standardized, highly valid Bush-Francis catatonia rating scale will facilitate the diagnosis of this disorder and taking a fast decision-making.
Reference
1. Benarous X., Raffin M., Ferrafiat V. et al. Catatonia in children and adolescents: New perspectives // Schizophrenia Research. 2018. Vol. 200. P. 56—67.
2. Fink M., Taylor M. A. The catatonia syndrome: forgotten but not gone// Archives of General Psychiatry. 2009. Vol. 66. P. 1173.
3. Heijden F. M. van der, Tuinier S., Arts N. J. et al. Catatonia: disappeared or under-diagnosed? // Psychopathology. 2005. Vol. 38. P. 3.
4. Sienaert P., Dhossche D. M., Vancampfort D. et al. A clinical review of the treatment of catatonia // Frontiers in Psychiatry. 2014. Vol. 5. P. 3—7. doi: 10.3389/ fpsyt.2014.00181.
5. Rajagopal S. Catatonia // Advances in Psychiatric Treatment. 2007. Vol. 13. P. 51—59.
6. Конорева А. Е., Цукарзи Э. Э., Мосолов С. Н. Кататония: патофизиология, диагностика и современные подходы к лечению // Современная терапия психических расстройств. 2019. № 4. С. 2—10.
7. Шмуклер А. Б. Кататония при соматических заболеваниях: роль анти-NMDA рецепторного энцефалита // Социальная и клиническая психиатрия. 2020. Т. 30, № 4. С. 87—89.
8. Chalasani P., Healy D., Morriss R. Presentation and frequency of catatonia in new admissions to two acute psychiatric admission units in India and Wales // Psychological Medicine. 2005. Vol. 35. P. 1667.
9. Penland H. R., Weder N., Tampi R. R. The catatonic dilemma expanded // Annals of General Psychiatry. 2006. Vol. 5. P. 14. doi: 10.1186/1744-859X-5-14.
10. Coffey M. J. Catatonia in adults: Epidemiology, clinical features, assessment, and diagnosis. URL: https://www.uptodate.com/contents/catatonia-in-adults-epide miology-clinical-features-assessment-and-diagnosis (дата обращения: 14.10.2021).
11. Bush G., Fink M., Petrides G. et al. Catatonia. I. Rating scale and standardized examination // Acta Psychiatrica Scandinavica. 1996. Vol. 93, № 2. P. 129—136.
12. Francis A. Catatonia: diagnosis, classification and treatment // Current Psychiatry Reports. 2010. Vol. 12. P. 180—185.
13. Rosebush P. I., Mazurek M. F. Catatonia: Clinical Features, Differential Diagnosis, and Treatment // Psychiatry for neurologists: Text-book /ed. by D. V. Jeste, J. H. Friedman. Totowa NJ, 2006. P. 81—92.
14. Seethalakshmi R., Dhavale S., Suggu K., Dewan M. Catatonic syndrome: importance of detection and treatment with lorazepam // Annals of Clinical Psychiatry. 2008. Vol. 20. P. 5.
16. Leonhard K. Aufteilung der endogenen Psychosen. Berlin, 1980.
17. Hauptman A. J., Benjamin S. The differential diagnosis and treatment of catatonia in children and adolescents // Harvard Review of Psychiatry. 2016. Vol. 24, № 6. P. 379—395.
18. Verbraeken R., Luykx J. J. Persistent catatonia following epileptic seizures: a case report and systematic literature search // BMC Psychiatry. 2018. Vol. 18. P. 350—355.
19. Alisky J. M. Is the immobility of advanced dementia a form of lorazepam-responsivе catatonia? // American Journal of Alzheimer’s Disease and Other Dementias. 2004. Vol. 19. P. 213—214.
20. Orum M. H., Aksoy I. Use of Electroconvulsive Therapy (ECT) in Hysterical Catatonia: Case Reports of Two Women, One Young and One Elderly // Journal of Case Reports and Studies. 2018. Vol. 6, № 3. P. 306—309. doi: 10.15744/2348-9820. 6.306.
21. Yacoub A., Kohen I., Francis A. et al. Catatonia with thrombotic thrombocytopenic purpura //Psychosomatics. 2004. Vol. 45. P. 363—364.
22. Hare D. J., Malone C. Catatonia and autistic spectrum disorders. Autism. 2004. Vol. 8. P. 183—195.
23. Dhossche D. M. Catatonia in Autism Spectrum Disorders: Diagnosis, Therapy, and Clinical Science // Autism and Developmental Disorders. 2019. Vol. 17, № 1. P. 24—35.
24. Miles J. H., Takahashi N., Muckerman J. et al. Catatonia in Down syndrome: systematic approach to diagnosis, treatment and outcome assessment based on a case series of seven patients // Neuropsychiatric Disease and Treatment. 2019. Vol. 15. Р. 2723—2741.
25. Davis E. J., Borde M. Wilson’s disease and catatonia // British Journal of Psychiatry. 1993. Vol. 162. P. 256—259.
26. Gingrich J. A., Rudnick-Levin F., Almeida C. et al. Cocaine and catatonia // American Journal of Psychiatry. 1998. Vol. 155. P. 1629.
27. Masi G., Mucci M., Floriani C. Acute catatonia after a single dose of ecstasy // Journal of the American Academy of Child and Adolescent Psychiatry. 2002. Vol. 41. Р. 892.
28. Yeh A. W., Lee J. W., Cheng T. C. et al. Clozapine withdrawal catatonia associated with cholinergic and serotonergic rebound hyperactivity: a case report // Clinical Neuropharmacology. 2004. Vol. 27. P. 216—218.
29. Lee J. W., Schwartz D. L. Catatonia associated with hyponatremia // Neuropsychiatry, Neuropsychology and Behavioral Neurology. 1997. Vol. 10. Р. 63—64.
30. Lai J. Y., Huang T. L. Catatonic features noted in patients with post-partum mental illness // Psychiatry and Clinical Neuroscience. 2004. Vol. 58. Р. 157—162.
31. Micaldi S. C., Dao Ch. W., Napier D. N., Samson J. A Case of Pediatric Catatonia // Kansas Journal of Medicine. 2021. Vol. 14. Р. 261—264.
32. Carroll B. T., Kirkhart R., Ahuja N., Soovere I. et al. Katatonia: A new conceptual understanding of catatonia and a new rating scale // Psychiatry (Edgemont). 2008. Vol. 5 (12). Р. 42—50.
33. Benarous X., Consoli A., Raffin M. et al. Validation of the Pediatric Catatonia Rating Scale (PCRS) // Schizophrenia Research. 2016. Vol. 176. Р. 378—386.
34. Hirjak D., Thomann P. A., Northoff G. et al. Deutsche Version der Northoff Catatonia Rating Scale (NCRS-dv) // Originalien Nervenarzt. 2017. Vol. 88. P. 787—796.
35. Roi C., Verret L., Peet B., Conrad E. J. Treatment of a Complex Case of Catatonia and Conversion Features With Electroconvulsive Therapy in a 14-Year-Old Male // Ochsner Journal. 2020. Vol. 20. P. 307—310. doi: 10.31486/toj.19.0026.
36. Taylor M. A., Fink M. Catatonia in psychiatric classification: a home of its own // American Journal of Psychiatry. 2003. Vol. 160. Р. 1233.
37. Moskowitz A. K. ‘Scared stiff’: catatonia as an evolutionary-based fear response // Psychological Review. 2004. Vol. 111. P. 984—1002.
38. Northoff G. What catatonia can tell us about “top-down modulation”: A neuropsychiatric hypothesis // Behavioral and brain sciences. 2002. Vol. 25. P. 555—604.
39. Sambataro F., Hirjak D., Fritze S. et al. Intrinsic neural network dynamics in catatonia // Human Brain Mapping. 2021. Vol. 42, № 18. Р. 6087—6098.
40. Northoff G., Eckert J., Fritze J. Glutamatergic dysfunction in catatonia? Successful treatment of three akinetic catatonic patients with the NMDA antagonist amantadine // Journal of Neurology, Neurosurgery and Psychiatry. 1997. Vol. 62. P. 404—406.
41. Osman A. A., Khurasani M. H. Lethal catatonia and neuroleptic malignant syndrome. A dopamine receptor shut-down hypothesis // British Journal of Psychiatry. 1994. Vol. 165, № 4. P. 548—50. doi: 10.1192/bjp.165.4.548.
42. Consoli A., Benmiloud M., Wachtel L. et al. Electroconvulsive therapy in adolescents with the catatonia syndrome: efficacy and ethics // Journal of ECT. 2010. Vol. 26, № 4. P. 259—265.